Dark

EOLS
Evolus, Inc. Common Stock
stock NASDAQ

At Close

Mar 23, 2026 3:59:58 PM EDT

4.69USD+1.078%(+0.05)1,324,851

4.68Bid 4.69Ask 0.01Spread

Pre-market

Mar 23, 2026 8:09:30 AM EDT

4.60USD-0.836%(-0.04)2,206

After-hours

Mar 20, 2026 4:00:30 PM EDT

4.64USD-0.215%(-0.01)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

305.13M

CEO

David Moatazedi

Headquarters

Newport Beach, California, USA

Industry

Drug Manufacturers-Specialty & Generic

Next Earnings

May 6, 2026 (44d)

XLV

EOLS Stats

Avg. Vol. 10 Day

1,000,151

Avg. Vol. 30 Day

1,306,472

Employees

Market Cap

305,131,353

Shares Out.

65,059,990

On/Off Exchange

60%/40%

6 Month Beta

1.46

1 Year Beta

1.21

2 Year Beta

1.17

3 Year Beta

1.10

52 Week Low

4.09

52 Week High

13.18

SMA50

4.83

SMA200

6.86

1 Week

-6.94%

1 Month

+8.31%

3 Month

-31.13%

6 Month

-24.23%

1 Year

-63.92%

2 Year

-66.04%

5 Year

-70.85%

Profile

evolus, inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the united states. it offers jeuveau, a proprietary 900 kilodalton purified botulinum toxin type a formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. the company was founded in 2012 and is headquartered in newport beach, california.

EOLS Stock Summary

Evolus, Inc. Common Stock (NASDAQ:EOLS) stock price today is $4.69, and today's volume is 1,324,851. EOLS is up 1.078% today. The 30 day average volume is 1,306,472. EOLS market cap is 305.13M with 65,059,990 shares outstanding.

.dark-mode .MLdF3q{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .MLdF3q{ color: #333333; background-color: white; border: 2px solid #333333; }EOLSEvolus, Inc. Common Stockstock NASDAQ

EOLS Stock Summary

EOLS
Evolus, Inc. Common Stock
stock NASDAQ